FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

RVL Pharmaceuticals plc: cashflow_financing

One fact, its scope and the complete path back to the official record.

Period: 2021-01-01 – 2021-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/bc7e7f1e-154b-4555-bb2b-69f82c535a30

Reported value

$-135.330M{"amount": -135330000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Entity
RVL Pharmaceuticals plc
Metric
cashflow_financing
Period
2021-01-01 – 2021-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001558370-22-004770 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T17:45:33.219005+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001739426/cashflow-financing/2021-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.